1. Sources, Occurrence, and Environmental Risk Assessment of Pharmaceuticals in the Ebro River Basin.
- Author
-
Gros, Meritxell, Petrovic, Mira, Ginebreda, Antoni, and Barceló, Damià
- Abstract
Freshwaters are an essential resource which must be available not only in the required quantity but also in a precise quality. Only less than 1% of the world΄s freshwater resources are readily available for human use, and even this resource is unevenly distributed among the countries. In developed countries, their contamination is the adverse outcome of incomplete wastewater treatment and improper disposal of sewage into surface and groundwater, which are the major renewable resources for sustainable drinking water production. In a vast array of contaminants of anthropogenic origin reaching our water supplies, pharmaceutically active compounds (PhACs) are among the ones with the biggest input into the environment. In the case of the Ebro river basin, pharmaceuticals can enter the environment through the effluent discharges of 186 WWTPs, and at some points, especially in drought periods, the effluents may represent a significant percentage of the total flow of the river. Besides these WWTP discharges other environmental exposure pathways of PhACs can be land applications (e.g., biosolids and water reuse) or concentrated animal feeding operations (CAFOs). The fact that existing WWTPs only treat wastewaters produced by a 62.8% of the basins total population and therefore, that a certain percentage of water remains untreated, may result in lower water quality in some affected areas. Even though pharmaceutical products are, until now, not included in the list of priority or dangerous substances of the Water Framework Directive (2000/60/EC), and thus, no environmental quality standards are stipulated (Directive 2008/105/EC), substances discharged into a basin should be controlled, as the same directive clearly establishes. This chapter will review the levels and distribution of pharmaceuticals detected in both waste and river waters from the Ebro river Basin and gives an example about the use of established hazard indexes to estimate the possible risks posed by the pharmaceutical levels detected towards different aquatic organisms (algae, daphnia, and fish). Results presented in this chapter were integrated in the FP6 European Union project AQUATERRA (contract no. 505428). [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF